Maxigen Biotech, Inc. engages in the development, manufacture, and sale of beauty care products. Its business activities include skin care, and biomedical division. Its Skin Care division face masks, facial cleansers, and body care products. Its Biomedical division offers medical products such as bone graft substitute, ophthalmic viscoelastic, collagen dental graft, collagen wound dressing, and dermal filler injection. The company was founded on December 3, 1998 and is headquartered in Taoyuan, Taiwan.